Response Rates to Venetoclax Based Therapies in Chronic Phase and Blast Transformed Chronic Myelomonocytic Leukemia

被引:1
|
作者
Csizmar, Clifford M. [1 ]
Saliba, Antoine N. [2 ]
Litzow, Mark R. [2 ]
Gangat, Naseema [2 ]
Al-Kali, Aref [2 ]
Foran, James M. [3 ]
Hogan, William J. [2 ]
Palmer, Jeanne M. [4 ]
Mangaonkar, Abhishek A. [2 ]
McCullough, Kirsten [2 ]
Tefferi, Ayalew [2 ]
Alkhateeb, Hassan B. [2 ]
Patnaik, Mrinal M. M. [2 ]
机构
[1] Mayo Clin, Dept Med, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin, Div Hematol Oncol & Blood & Marrow Transplanat &, Jacksonville, FL 32224 USA
[4] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
关键词
D O I
10.1182/blood-2022-165470
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:12238 / 12240
页数:3
相关论文
共 50 条
  • [41] Chronic urticaria associated with chronic myelomonocytic leukemia
    Alonso, R
    Cisteró-Bahíma, A
    Enrique, E
    Besses, C
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 2000, 10 (06): : 380 - 381
  • [42] Leukemia Cutisin Chronic Myelomonocytic Leukemia
    Zhu, Hongbin
    Lu, Xuechun
    Zhang, Lei
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 351 (01): : 111 - 111
  • [43] Lysosomal Acid Lipase a (LIPA) Modulates Leukemia Stem Cell (LSC) Response to Venetoclax/TKI Combination Therapy in Blast Phase Chronic Myeloid Leukemia
    Minhajuddin, Mohd
    Ye, Haobin
    Winters, Amanda C.
    Pei, Shanshan
    Khan, Nabilah
    Stevens, Brett M.
    Adane, Biniam
    Amaya, Maria L.
    Inguva, Anagha
    Krug, Anna
    Gasparetto, Maura
    Sherbenou, Daniel W.
    Pollyea, Daniel A.
    Smith, Clayton
    Jordan, Craig T.
    BLOOD, 2021, 138
  • [44] Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia
    Minhajuddin, Mohd
    Winters, Amanda
    Ye, Haobin
    Pei, Shanshan
    Stevens, Brett
    Gillen, Austin
    Engel, Krysta
    Gipson, Stephanie
    Ransom, Monica
    Amaya, Maria
    Inguva, Anagha
    Gasparetto, Maura
    Althoff, Mark J.
    Miller, Regan
    Shelton, Ian
    Tolison, Hunter
    Krug, Anna
    Culp-Hill, Rachel
    D'Alessandro, Angelo
    Sherbenou, Daniel W.
    Pollyea, Daniel A.
    Smith, Clayton
    Jordan, Craig T.
    HAEMATOLOGICA, 2024, 110 (01) : 103 - 116
  • [45] Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
    Braun, Thorsten
    Itzykson, Raphael
    Renneville, Aline
    de Renzis, Benoit
    Dreyfus, Francois
    Laribi, Kamel
    Bouabdallah, Krimo
    Vey, Norbert
    Toma, Andrea
    Recher, Christian
    Royer, Bruno
    Joly, Bertrand
    Vekhoff, Anne
    Lafon, Ingrid
    Sanhes, Laurence
    Meurice, Guillaume
    Orear, Cedric
    Preudhomme, Claude
    Gardin, Claude
    Ades, Lionel
    Fontenay, Michaela
    Fenaux, Pierre
    Droin, Nathalie
    Solary, Eric
    BLOOD, 2011, 118 (14) : 3824 - 3831
  • [46] Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
    Geyer, Julia T.
    Tam, Wayne
    Liu, Yen-Chun
    Chen, Zhengming
    Wang, Sa A.
    Bueso-Ramos, Carlos
    Oak, Jean
    Arber, Daniel A.
    Hsi, Eric
    Rogers, Heesun J.
    Levinson, Katherine
    Bagg, Adam
    Hassane, Duane C.
    Hasserjian, Robert P.
    Orazi, Attilio
    MODERN PATHOLOGY, 2017, 30 (09) : 1213 - 1222
  • [47] Chronic myelomonocytic leukemia (CMML)
    Geissler, Klaus
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (1-2) : 1 - 2
  • [48] Chronic myelomonocytic leukemia.
    Bennett J.M.
    Current Treatment Options in Oncology, 2002, 3 (3) : 221 - 223
  • [49] Basophilic blast phase of chronic myelogenous leukemia
    Babiker, Hani M.
    Proytcheva, Maria
    BLOOD, 2014, 124 (15) : 2464 - 2464
  • [50] TREATMENT OF THE BLAST PHASE OF CHRONIC MYELOGENOUS LEUKEMIA
    THOMAS, ED
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (24): : 1550 - 1550